190 results on '"Vilar, Lucio"'
Search Results
2. “Micromegaly”: Acromegaly with apparently normal GH, an entity on its own?
3. Accuracy of the 10 μg desmopressin test for differential diagnosis of Cushing syndrome: a systematic review and meta-analysis
4. Accuracy of the 10 mg desmopressin test for differential diagnosis of Cushing syndrome: a systematic review and meta-analysis.
5. AVALIAÇÃO DA RESISTÊNCIA INSULÍNICA EM INDIVÍDUOS COM OBESIDADE GRAVE CANDIDATOS À CIRURGIA BARIÁTRICA.
6. Acromegaly: clinical features at diagnosis
7. Challenges in the diagnosis and management of acromegaly: a focus on comorbidities
8. Medical combination therapies in Cushing’s disease
9. Sensorineural hearing loss in acromegalic patients under treatment
10. Withdrawal of dopamine agonist treatment in patients with hyperprolactinaemia:A systematic review and meta-analysis
11. Withdrawal of dopamine agonist treatment in patients with hyperprolactinaemia: A systematic review and meta‐analysis
12. Can we predict long-term remission after somatostatin analog withdrawal in patients with acromegaly? Results from a multicenter prospective trial
13. Subclinical Ventricular Dysfunction in Long-Term Acromegaly Assessed by Speckle-Tracking Echocardiography
14. Multiple facets in the control of acromegaly
15. Thyroid cancer in patients with acromegaly: a case–control study
16. gsp Mutation Is Not a Molecular Biomarker of Long-Term Response to First-Generation Somatostatin Receptor Ligands in Acromegaly
17. Role of the addition of cabergoline to the management of acromegalic patients resistant to longterm treatment with octreotide LAR
18. Adrenal Incidentalomas: Diagnostic Evaluation and Long-Term Follow-Up
19. Management of prolactinomas in Brazil: an electronic survey
20. Effectiveness of cabergoline in monotherapy and combined with ketoconazole in the management of Cushing’s disease
21. Criteria for the definition of Pituitary Tumor Centers of Excellence (PTCOE): A Pituitary Society Statement
22. Increase of Classic and Nonclassic Cardiovascular Risk Factors in Patients with Acromegaly
23. Machine Learning-based Prediction Model for Treatment of Acromegaly With First-generation Somatostatin Receptor Ligands
24. Normal Sensorineural Hearing, and Peripheral/Central Nervous Auditory System Transmission in Acromegalic Patients under Treatment (Evaluated by Brainstem Auditory Evoked Potentials and Pure Tone Audiometry)
25. Management of hypopituitarism: a perspective from the Brazilian Society of Endocrinology and Metabolism
26. Guia Prático em Neuroendocrinologia
27. Relationship between Prolactin, Chronic Kidney Disease, and Cardiovascular Risk
28. SAT-310 Analysis of the Influence of Glucocorticoid Receptor Gene Polymorphism BCL-1 on Clinical and Psychiatric Manifestations in Brazilian Patients with Cushing’s Disease
29. SUBSTANTIAL SHRINKAGE OF ADENOMAS COSECRETING GROWTH HORMONE AND PROLACTIN WITH USE OF CABERGOLINE THERAPY
30. ASSOCIATION BETWEEN FOOD INTAKE, BOTH BODY COMPOSITION AND LIFESTYLE IN PATIENTS UNDERGOING BARIATRIC SURGERY.
31. Brazilian multicenter study on pegvisomant treatment in acromegaly
32. The impact of clomiphene citrate as add-on therapy in male acromegalic patients non-responsive to combined medical therapy
33. Medical treatment of cushing's disease during pregnancy with Ketoconazole and Cabergoline - Report of 3 cases
34. Diagnostic evaluation of a large cohort of Brazilian patients with endogenous Cushing's syndrome
35. SUN-445 A Brazilian Multicentric Study Evaluating Pregnancies Induced by Cabergoline in Patients Harboring Prolactinomas
36. Controversial issues in the management of hyperprolactinemia and prolactinomas : an overview by the Neuroendocrinology Department of the Brazilian Society of Endocrinology and Metabolism
37. Serum levels of vitamin A, visual function and ocular surface after bariatric surgery
38. Pitfalls in the Diagnostic Evaluation of Hyperprolactinemia
39. Perception of body image by patients undergoing bariatric surgery
40. The role of clomiphene citrate in the resolution of hypogonadism in male patients with prolactinomas under cabergoline therapy
41. Clinical and mri findings among 120 patients with macroproprolactinemia: results from a retrospective study
42. Very high prolactin levels associated to domperidone therapy
43. Lanreotide autogel may be an effective approach for acromegalic patients who failed octreotide lar
44. Efficacy and tolerability of cabergoline in a cohort of 160 prolactinomas at weekly doses of up to 9 mg
45. The importance of routine screening for macroprolactin in symptomatic patients with idiopathic hyperprolactinemia
46. Controversial issues in the management of hyperprolactinemia and prolactinomas – An overview by the Neuroendocrinology Department of the Brazilian Society of Endocrinology and Metabolism
47. A review of Cushing's disease treatment by the Department of Neuroendocrinology of the Brazilian Society of Endocrinology and Metabolism
48. Electronic survey of management of hyperprolactinemia in Brazil: Endocrinologists versus gynecologists
49. Effect of the addition of lanreotide autogel to the treatment of an aggressive prolactinoma - a case report
50. The use of increasing doses of cabergoline in the management of cabergoline-resistant prolactinomas
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.